Filed: 8/12/2024ACC: 0001104659-24-088269
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 99 equity positions with a total reported market value of $250.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
99
Positions
$250.6K
Total AUM (reported)
16.34M
Total Shares
Allocation by class
COMMON$250.6K100.0%
Portfolio Concentration
Top 3$116.6K46.5%
4–10$55.0K21.9%
11–25$45.3K18.1%
Rest$33.7K13.4%
Top 3 weight
46.5%
Top 10 weight
68.5%
Voting Authority Distribution
Total shares with voting rights: 16.34M
Sole
Full voting authority
16.34M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other99
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings99
Rows:
Calumet Specialty Products Partners, LP
DFNDShares4.33M
TypeSH
Market value$69.4K
27.70%
Sole
4.33M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$26.6K
10.60%
Sole
225K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares112.22K
TypeSH
Market value$20.6K
8.21%
Sole
112.22K
Shared
0.00
None
0.00
The Panagram BBB-B CLO ETF
DFNDShares542.87K
TypeSH
Market value$14.6K
5.84%
Sole
542.87K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares3.07M
TypeSH
Market value$9.5K
3.79%
Sole
3.07M
Shared
0.00
None
0.00
Ligand Pharmaceuticals Incorporated
DFNDShares85K
TypeSH
Market value$7.2K
2.86%
Sole
85K
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares248.74K
TypeSH
Market value$7.0K
2.78%
Sole
248.74K
Shared
0.00
None
0.00
The Invesco AAA Floating Rate Note ETF
DFNDShares237.75K
TypeSH
Market value$6.1K
2.44%
Sole
237.75K
Shared
0.00
None
0.00
Ardelyx, Inc.
DFNDShares772.87K
TypeSH
Market value$5.7K
2.29%
Sole
772.87K
Shared
0.00
None
0.00
Medical Facilities Corp
DFNDShares534.21K
TypeSH
Market value$4.9K
1.97%
Sole
534.21K
Shared
0.00
None
0.00
Avadel Pharmaceuticals plc
DFNDShares333K
TypeSH
Market value$4.7K
1.87%
Sole
333K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares20.98K
TypeSH
Market value$4.2K
1.69%
Sole
20.98K
Shared
0.00
None
0.00
OmniAb Inc.
DFNDShares1.12M
TypeSH
Market value$4.2K
1.67%
Sole
1.12M
Shared
0.00
None
0.00
Viking Therapeutics, Inc.
DFNDShares76.04K
TypeSH
Market value$4.0K
1.61%
Sole
76.04K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares212K
TypeSH
Market value$3.3K
1.31%
Sole
212K
Shared
0.00
None
0.00
Verona Pharma PLC.
DFNDShares203K
TypeSH
Market value$2.9K
1.17%
Sole
203K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares53.40K
TypeSH
Market value$2.7K
1.08%
Sole
53.40K
Shared
0.00
None
0.00
Digimarc Corporation
DFNDShares83.56K
TypeSH
Market value$2.6K
1.03%
Sole
83.56K
Shared
0.00
None
0.00
Inozyme Pharma, Inc.
DFNDShares564.55K
TypeSH
Market value$2.5K
1.00%
Sole
564.55K
Shared
0.00
None
0.00
GSK plc
DFNDShares65K
TypeSH
Market value$2.5K
1.00%
Sole
65K
Shared
0.00
None
0.00
Immunovant Inc.
DFNDShares91.50K
TypeSH
Market value$2.4K
0.96%
Sole
91.50K
Shared
0.00
None
0.00
Ironwood Pharmaceuticalss, Inc.
DFNDShares370K
TypeSH
Market value$2.4K
0.96%
Sole
370K
Shared
0.00
None
0.00
CSX Corporation
DFNDShares70K
TypeSH
Market value$2.3K
0.93%
Sole
70K
Shared
0.00
None
0.00
Enstar Group Limited
DFNDShares7.50K
TypeSH
Market value$2.3K
0.91%
Sole
7.50K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares265.97K
TypeSH
Market value$2.2K
0.87%
Sole
265.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet Specialty Products Partners, LPDFND | Common | 4.33M | SH | $69.4K 27.70% | 4.33M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $26.6K 10.60% | 225K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 112.22K | SH | $20.6K 8.21% | 112.22K | 0.00 | 0.00 |
The Panagram BBB-B CLO ETFDFND | Common | 542.87K | SH | $14.6K 5.84% | 542.87K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 3.07M | SH | $9.5K 3.79% | 3.07M | 0.00 | 0.00 |
Ligand Pharmaceuticals IncorporatedDFND | Common | 85K | SH | $7.2K 2.86% | 85K | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 248.74K | SH | $7.0K 2.78% | 248.74K | 0.00 | 0.00 |
The Invesco AAA Floating Rate Note ETFDFND | Common | 237.75K | SH | $6.1K 2.44% | 237.75K | 0.00 | 0.00 |
Ardelyx, Inc.DFND | Common | 772.87K | SH | $5.7K 2.29% | 772.87K | 0.00 | 0.00 |
Medical Facilities CorpDFND | Common | 534.21K | SH | $4.9K 1.97% | 534.21K | 0.00 | 0.00 |
Avadel Pharmaceuticals plcDFND | Common | 333K | SH | $4.7K 1.87% | 333K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 20.98K | SH | $4.2K 1.69% | 20.98K | 0.00 | 0.00 |
OmniAb Inc.DFND | Common | 1.12M | SH | $4.2K 1.67% | 1.12M | 0.00 | 0.00 |
Viking Therapeutics, Inc.DFND | Common | 76.04K | SH | $4.0K 1.61% | 76.04K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 212K | SH | $3.3K 1.31% | 212K | 0.00 | 0.00 |
Verona Pharma PLC.DFND | Common | 203K | SH | $2.9K 1.17% | 203K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 53.40K | SH | $2.7K 1.08% | 53.40K | 0.00 | 0.00 |
Digimarc CorporationDFND | Common | 83.56K | SH | $2.6K 1.03% | 83.56K | 0.00 | 0.00 |
Inozyme Pharma, Inc.DFND | Common | 564.55K | SH | $2.5K 1.00% | 564.55K | 0.00 | 0.00 |
GSK plcDFND | Common | 65K | SH | $2.5K 1.00% | 65K | 0.00 | 0.00 |
Immunovant Inc.DFND | Common | 91.50K | SH | $2.4K 0.96% | 91.50K | 0.00 | 0.00 |
Ironwood Pharmaceuticalss, Inc.DFND | Common | 370K | SH | $2.4K 0.96% | 370K | 0.00 | 0.00 |
CSX CorporationDFND | Common | 70K | SH | $2.3K 0.93% | 70K | 0.00 | 0.00 |
Enstar Group LimitedDFND | Common | 7.50K | SH | $2.3K 0.91% | 7.50K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 265.97K | SH | $2.2K 0.87% | 265.97K | 0.00 | 0.00 |
Page 1 of 4